Neuroblastoma Screening (PDQ®)–Health Professional Version
Neuroblastoma screening, according to solid evidence, does not lead to decreased mortality and exposes infants to potential serious harms. Get detailed information about neuroblastoma and the potential benefits and harms of screening in this summary for clinicians.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/1929/syndication
- Syndication ID: 1395
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Saturday, September 14, 2013 at 09:00 AM
- Date Syndication Updated: Monday, August 05, 2019 at 07:41 PM
Tags
General:
health
screening
version
professional
neuroblastoma
disease screening
Embed Code Snippet
To get the embed code snippet please Login.
